Company intelligence / Profile preview

ATEKA Tx

Ownership: Private
Development stage: Preclinical

Overview

In a HD model of mice, their lead compounds have shown reduction of tremors, a key symptom of the disease. The company intends to perform regulatory pre-clinical studies necessary to test its lead in Amyotrophic Lateral Sclerosis[1].

Therapeutic areas: Neurology
Modalities: Small molecules
Industry: Biotech

Partnerships

Seeking partnerships with Biotech and Pharma players in CNS areas[1]

Beyond the preview

Go deeper on ATEKA Tx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATEKA Tx.

Explore the full profile